SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, Paolo Eusebi, Shiji Varghese, Mohammad M. Qureshi, Andrea Dardis, Marta Deganuto, Claudia Carlo, Anna Castrioto, Chiara Balducci, Silvia Paciotti, Nicola Tambasco, Bruno Bembi, Laura Bonanni, Marco Onofrj, Aroldo Rossi, Tommaso Beccari, Omar El-Agnaf, Paolo Calabresi, Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease, Movement Disorders, 2014, 29, 8
  2. 2
    Robert E. Boyd, Kenneth J. Valenzano, Correction of lysosomal dysfunction as a therapeutic strategy for neurodegenerative diseases, Bioorganic & Medicinal Chemistry Letters, 2014, 24, 14, 3001

    CrossRef

  3. 3
    Lucilla Parnetti, Lucia Farotti, Paolo Eusebi, Davide Chiasserini, Claudia De Carlo, David Giannandrea, Nicola Salvadori, Viviana Lisetti, Nicola Tambasco, Aroldo Rossi, Nour K. Majbour, Omar El-Agnaf, Paolo Calabresi, Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  4. 4
    M. Siebert, E. Sidransky, W. Westbroek, Glucocerebrosidase is shaking up the synucleinopathies, Brain, 2014, 137, 5, 1304

    CrossRef

  5. 5
    David C. Schöndorf, Massimo Aureli, Fiona E. McAllister, Christopher J. Hindley, Florian Mayer, Benjamin Schmid, S. Pablo Sardi, Manuela Valsecchi, Susanna Hoffmann, Lukas Kristoffer Schwarz, Ulrike Hedrich, Daniela Berg, Lamya S. Shihabuddin, Jing Hu, Jan Pruszak, Steven P. Gygi, Sandro Sonnino, Thomas Gasser, Michela Deleidi, iPSC-derived neurons from GBA1-associated Parkinson’s disease patients show autophagic defects and impaired calcium homeostasis, Nature Communications, 2014, 5,

    CrossRef

  6. 6
    K. E. Murphy, A. M. Gysbers, S. K. Abbott, N. Tayebi, W. S. Kim, E. Sidransky, A. Cooper, B. Garner, G. M. Halliday, Reduced glucocerebrosidase is associated with increased  -synuclein in sporadic Parkinson's disease, Brain, 2014, 137, 3, 834

    CrossRef

  7. 7
    P. J. Schultheis, S. M. Fleming, A. K. Clippinger, J. Lewis, T. Tsunemi, B. Giasson, D. W. Dickson, J. R. Mazzulli, M. E. Bardgett, K. L. Haik, O. Ekhator, A. K. Chava, J. Howard, M. Gannon, E. Hoffman, Y. Chen, V. Prasad, S. C. Linn, R. J. Tamargo, W. Westbroek, E. Sidransky, D. Krainc, G. E. Shull, Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited  -synuclein accumulation and age-dependent sensorimotor deficits, Human Molecular Genetics, 2013, 22, 10, 2067

    CrossRef

  8. 8
    S. P. Sardi, J. Clarke, C. Viel, M. Chan, T. J. Tamsett, C. M. Treleaven, J. Bu, L. Sweet, M. A. Passini, J. C. Dodge, W. H. Yu, R. L. Sidman, S. H. Cheng, L. S. Shihabuddin, Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies, Proceedings of the National Academy of Sciences, 2013, 110, 9, 3537

    CrossRef

  9. 9
    Lucilla Parnetti, Anna Castrioto, Davide Chiasserini, Emanuele Persichetti, Nicola Tambasco, Omar El-Agnaf, Paolo Calabresi, Cerebrospinal fluid biomarkers in Parkinson disease, Nature Reviews Neurology, 2013, 9, 3, 131

    CrossRef

  10. 10
    Karin D. Dijk, Emanuele Persichetti, Davide Chiasserini, Paolo Eusebi, Tommaso Beccari, Paolo Calabresi, Henk W. Berendse, Lucilla Parnetti, Wilma D. J. Berg, Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease, Movement Disorders, 2013, 28, 6
  11. 11
    Matthew Swan, Rachel Saunders-Pullman, The Association Between ß-Glucocerebrosidase Mutations and Parkinsonism, Current Neurology and Neuroscience Reports, 2013, 13, 8

    CrossRef

  12. 12
    Tessa N Campbell, Francis YM Choy, Gaucher disease and the synucleinopathies: refining the relationship, Orphanet Journal of Rare Diseases, 2012, 7, 1, 12

    CrossRef

  13. 13
    S. Pablo Sardi, Priyanka Singh, Seng H. Cheng, Lamya S. Shihabuddin, Michael G. Schlossmacher, MutantGBA1Expression and Synucleinopathy Risk: First Insights from Cellular and Mouse Models, Neurodegenerative Diseases, 2012, 10, 1-4, 195

    CrossRef

  14. 14
    Gilbert J. Ho, Willie Liang, Masaaki Waragai, Kazunari Sekiyama, Eliezer Masliah, Makoto Hashimoto, Bridging Molecular Genetics and Biomarkers in Lewy Body and Related Disorders, International Journal of Alzheimer's Disease, 2011, 2011, 1

    CrossRef

  15. 15
    N.R.S. Goldberg, A.K. Haack, N.S. Lim, O.K. Janson, C.K. Meshul, Dopaminergic and behavioral correlates of progressive lesioning of the nigrostriatal pathway with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Neuroscience, 2011, 180, 256

    CrossRef

  16. 16
    Tamar Shachar, Christophe Lo Bianco, Alessandra Recchia, Christoph Wiessner, Annick Raas-Rothschild, Anthony H. Futerman, Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond, Movement Disorders, 2011, 26, 9
  17. 17
    Philipp Spitzer, Hans Wolfgang Klafki, Kaj Blennow, Luc Buée, Hermann Esselmann, Sanna-Kaisa Herruka, Connie Jimenez, Peter Klivenyi, Piotr Lewczuk, Juan Manuel Maler, Katrin Markus, Helmut E. Meyer, Chris Morris, Thorsten Müller, Markus Otto, Lucilla Parnetti, Hilkka Soininen, Susanna Schraen, Charlotte Teunissen, Laszlo Vecsei, Henrik Zetterberg, Jens Wiltfang, cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases, International Journal of Alzheimer's Disease, 2010, 2010, 1

    CrossRef

  18. 18
    Karin D. van Dijk, Charlotte E. Teunissen, Benjamin Drukarch, Connie R. Jimenez, Henk J. Groenewegen, Henk W. Berendse, Wilma D.J. van de Berg, Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach, Neurobiology of Disease, 2010, 39, 3, 229

    CrossRef

  19. 19
    Michael Eller, David R. Williams, Biological fluid biomarkers in neurodegenerative parkinsonism, Nature Reviews Neurology, 2009, 5, 10, 561

    CrossRef

  20. 20
    Sabata Martino, Ilaria di Girolamo, Antonio Orlacchio, Alessandro Datti, Aldo Orlacchio, MicroRNA Implications across Neurodevelopment and Neuropathology, Journal of Biomedicine and Biotechnology, 2009, 2009, 1

    CrossRef

  21. 21
    Brit Mollenhauer, Claudia Trenkwalder, Neurochemical biomarkers in the differential diagnosis of movement disorders, Movement Disorders, 2009, 24, 10
  22. 22
    Antonio Orlacchio, Giorgio Bernardi, Aldo Orlacchio, Sabata Martino, Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS, Expert Opinion on Therapeutic Patents, 2008, 18, 10, 1161

    CrossRef